2010
DOI: 10.1590/s1679-45082010ao1789
|View full text |Cite
|
Sign up to set email alerts
|

Administration of BAY 41-2272 prevents bladder dysfunction in nitric-oxide deficient rats

Abstract: Our data show that long-term oral administration of BAY 41-2272 counteracts the bladder dysfunction seen in NO-deficient rats, indicating that restoration of the NO-cGMP pathway by this compound may be of beneficial value to treat bladder symptoms.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2017
2017
2017
2017

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 29 publications
1
0
0
Order By: Relevance
“…The same result was found in chronically L-NAME treated rats (35) and was due to DSM super sensitivity to muscarinic agonists via increases in the levels of [ 3 H] inositol phosphate (IP 3 ), accompanied by reduction of β 3 -adrenoceptor-mediated DSM relaxations (23). Aminoguanidine treatment decreased NVC in BOO mice, as shown in BOO rats treated with the same drug, due to attenuation in fibrosis.…”
Section: Discussionsupporting
confidence: 68%
“…The same result was found in chronically L-NAME treated rats (35) and was due to DSM super sensitivity to muscarinic agonists via increases in the levels of [ 3 H] inositol phosphate (IP 3 ), accompanied by reduction of β 3 -adrenoceptor-mediated DSM relaxations (23). Aminoguanidine treatment decreased NVC in BOO mice, as shown in BOO rats treated with the same drug, due to attenuation in fibrosis.…”
Section: Discussionsupporting
confidence: 68%